Prevalence of Nasal Carriage of Neisseria meningitidis among Umrah Visitors and Pilgrims during Umrah and Hajj Season.

Size: px
Start display at page:

Download "Prevalence of Nasal Carriage of Neisseria meningitidis among Umrah Visitors and Pilgrims during Umrah and Hajj Season."

Transcription

1 Global Advanced Research Journal of Microbiology (ISSN: ) Vol. 2(9) pp , October, 2013 Available online Copyright 2013 Global Advanced Research Journals Full Length Research Paper Prevalence of Nasal Carriage of Neisseria meningitidis among Umrah Visitors and Pilgrims during Umrah and Hajj Season. Samy S. Ashgar, Hamdy M. El-Said, Ayman Johargy, Aiman M. Momenah, Atif Asghar, Ashraf E. Sorour, Ameen Alherabi, Bassam H Mashat and Ahmad Aalam. Department of Medical Microbiology - Faculty of Medicine and Center of Excellence for Hajj and Umrah Research - Umm Al-Qura University - Makkah Accepted 11 July, 2013 A total of 3081 specimens collected from 2412 Umrah and pilgrims to survey and surveillance Neisseria meningitidis. About 15 nationalities contributed in this study; the greatest number was from India (481) and the lowest one was from Jordan (1). Turkish and British recorded significant results (p= value 0.04 and 0.006, respectively) among Umrah and Indian (p= value ) in pilgrims colonized by Neisseria meningitidis. Out of 232 Neisseria meningitidis isolated from Umrah and pilgrims, 0 and 2 of serotype W135 were isolated before and, 2 and 5 were isolated after Umrah and Hajj respectively. Neisseria meningitides showed (8.3%) before Hajj and (10.3%) after Hajj resistant to Azithromycin antibiotic. Keywords: Umrah, Hajj, Neisseria meningitidis, serogroup. INTRODUCTION Hajj is the largest annual gathering of its kind in the world that bring over two million people together in a small, geographically-confined area. All adult Muslims who are physically and financially able to do so have a religious obligation to make the pilgrimage once in their lifetime and over two million from around the world gather in Mecca each year. Similarly, many Muslims like to come each year to Mecca during Umrah season between Rabi I and Ramadan to perform Umrah rituals (Month of Ramadan usually shows the highest peak of crowding). The congregation of so many people from different parts *Corresponding Author s hamdimustafa1@gmail.com of the world in unavoidably overcrowded conditions within a confined area for a defined period of time presents many public health challenges and health risks are greatly increased with potential for both local and international consequences. One of the main health problems correlated with crowding is respiratory tract and meningitis infections due to its ease of transmission by air droplets. These infections can be transmitted from infected people and more significantly from asymptomatic carriers due to absence of symptoms (Qureshi et al., 2000, and Wilder- Smith and Memish, 2003). The human nasopharynx and nares are densely colonized by a broad variety of microorganisms including commensal bacteria as well as potentially pathogenic bacteria (PPB) mainly: Neisseria meningitidis. Studies

2 142. Glo. Adv. Res. J. Microbiol. have shown that colonization with PPB is a major contributing factor for respiratory and extra-respiratory infections including pneumonia, sepsis, and meningitis in PPB carriers as well as their closed contacts (Tenover and Gaynes, 2000; Peacock et al., 2001; Ruoff et al., 2003; Cardozo et al., 2006; Musher, 2005 and Kadioglu et al., 2008). The reported rates of PPB colonization acquisition and carriage vary extensively between different studies and geographical sites (Fontanals et al., 2000; Peacock et al., 2001 andmelles et al., 2007). These differences have been related to genetic background variables and socioeconomic conditions including housing, access to health care, poor hygiene, and overcrowded living conditions (Garcia-Rodriguez and Martinez, 2002). This manuscript studied N. meningitidis in Umrah, pilgrims and carriers during Umrah and Hajj seasons in order to determine colonization of those bacteria in different ethnic groups, to find out any significant correlation between carriage rate and ethnic group, prevalence of N. meningitidis serotypes, and antibiotic resistance bacterial isolates. SUBJECT AND METHODS Subject of the study This study was performed on 979 Umrah from different nationalities including; 129 Turkish, 127 Indonesian, 102 Pakistani, 99 Syrian, 98 Nigerian, 79 Egyptian, 77 Iranian, 71 Indian, 56 British, 56 Iraqi, 39 Malaysian, 27 Libyan, 14 Swedish, 4 American and 1 Jordanian, during the period from Rabi-Al-Awwal to end of Ramadan 1430H and also in 1430H Pilgrims from different nationalities (1433 people) including; 481 Indian, 252 Nigerian, 95 Indonesian, 90 Libyan, 68 Syrian, 46 British, 35 Turkish, 11 Australian, 3 Swedish, 2 Iranian, 150 Pakistani, 100 Cameroon,50 Mali and 50 South Africa during the period from Zo-Alkaeda to end of Zo-Alhejja 1430H in the Microbiology research Laboratory, Faculty of Medicine, Umm Al-Qura University. Informed consent was obtained from all subjects prior to study enrollment. Collection of specimens Around 1958/2046 Samples were collected from Umrah /Pilgrims, at arrival to King Abdul-Aziz International Airport (KAAIA); Saudi Arabia and before leaving the country. Data forms including; nationality, age, sex, smoking, coughing, antibiotic usage, date of collection, contacts numbers for the group's leaders, were recorded for each /Pilgrims. The remaining swabs were then collected before departure from (KAAIA) from the same /pilgrims or at least from Umrah /pilgrims on the same group. Transportation of the specimens All Samples were collected on Amies transport swabs media to insure the survival of pathogens in specimens collected on swabs and transported to the Microbiology research laboratory without any delay. Cultivation of specimens All samples were collected processed in the research Laboratory according to the standard microbiological methods under complete aseptic conditions. Nasopharyngeal swabs were inoculated on chocolate agar and selective modified Thayer Martin agar (MTM, Sigma) and incubated at 37 o C in CO 2 incubator. Isolation and Identification of Neisseria meningitidis Neisseria meningitidis was isolated from Thayer Martin medium which was grown after an overnight incubation in CO 2 incubator. The identification was confirmed microscopically by the characteristic appearance as Gram negative diplococci after being stained by Gram stain. An oxidase test was also performed, in which the organism is characteristic positive. All Neisseria meningitidis isolates were then confirmed using VITEK 2 systems compact 15 "biomerieux". Identification of bacteria using VITEK 2 Machine About 3.0 ml of sterile saline (aqueous 0.45% NaCL, PH 7.0) was placed into a clear plastic test tube. Then sufficient number of pure bacterial colonies was transferred to the tube containing the saline to make a homogenous suspension with an equivalent density of McFarland (N o. 2.9 to3.2) using Calibrated VITEK 2 DENSICHEK. The tube was then placed in the cassette with the identification card and data entry. Serotyping of Neisseriameningitidis Neisseria meningitidisserogrouping was performed by using specific antisera latex slide agglutination (Neisseria meningitidis Antisera, BD Difco laboratories, USA): Neisseria meningitidis antiserum poly contain groups (A, B, C and D), Neisseria meningitidis antiserum Poly 2 contain groups (X, Y and Z), Neisseria meningitidis

3 Ashgar et al. 143 Table 1. Prevalence of Neisseria meningitidis isolated from different nationalities of the Umrah during 1430H season Nationality of tested N o. *= significant; **= highly significant Before Umrah + Umrah - Umrah After Umrah + Umrah - Umrah N o. % N o. % N o. % N o. % P-value Turkish P = 0.04* Indonesian P = 0.7 Pakistani P = 1.0 Syrian P = 0.7 Nigerian P = 0.7 Egyptian P = 0.6 Iranian P = 0.1 Indian P = 0.5 British P = 0.006** Iraqian P = 1.0 Malaysian P = 0.5 Libyan Sweden American P = 0.1 Jordanian Total P = ** antiserum group B and Neisseria meningitidis antiserum group W135. Preserved N.meningitides was subcultured on Thayer Martin medium before being incubated in CO 2 incubator for 24 hour to obtain a pure culture. After the 24 hour incubation, one drop of the DifcoNeisseria meningitidisantiserum was placed on agglutination slide, and then a loopfull of growth of Neisseria meningitidis was then transferred to the drop of the antiserum and mixed thoroughly. The slide was then rotated for one minute. A positive result was reported if agglutination appeared within one minute, while a negative result was reported if there was a positive resultno agglutination within one minute. STATISTICAL METHODS All statistical calculations were done using computer programs.microsoft excel version 10 and spss (statistica package for the social science version 20.00) statistical program at 0.05, 0.01 and level of probability (Snedecor and Cochran, 1982). Data was presented using percentage. Comparison of percentage was done using the chi square tests. RESULTS Distribution of Neisseria meningitidis prevalence in Umrah during the 1430H season according to different nationalities: In this study 80 Neisseria meningitidis isolates were isolated from Umrah, table (1). The carriage rate of Neisseria meningitidis as potentially pathogenic bacteria was the highest among the Umrah (2.5%) before performing Umrah and (5.7%) after performing Umrah. In addition, the carriage rate of all PPB among the Umrah was more after Umrah than before Umrah. The Iranian Umrah were the most ethnic group carries Neisseria meningitides before performing Umrah (7.79%). While the American Umrah were the most ethnic group carries Neisseria meningitides after performing Umrah (75%). Distribution of Neisseria meningitidis prevalence in Pilgrims during the Hajj 1430H season according to different nationalities: In this study 152 Neisseria meningitides isolates were isolated from Pilgrims, table (2). The carriage rate of

4 144. Glo. Adv. Res. J. Microbiol. Table 2. Prevalence of Neisseria meningitidis isolated from different nationalities of the Pilgrims during the Hajj 1430H season Nationality Before Hajj N o. of Pilgrims tested + Pilgrims - Pilgrims After Hajj N o. of Pilgrims tested + Pilgrims - Pilgrims N o. % N o. % N o. % N o. % Indian P = ** Nigerian P = 0.2 Indonesian P = 0.5 Libyan P = 1.0 Syrian P = 0.4 British P = 1.0 Turkish P = 0.2 Australian P = 1.0 Swedish P = 1.0 Iranian P = 1.0 Pakistani Cameroon Mali South Africa Total P = 0.03* P-value *= significant; **= highly significant Neisseria meningitidis as potentially pathogenic bacteria was the highest among the pilgrims (7.3%)before performing Hajj and (11.1%) after performing Hajj. However, the Swedish pilgrims were the most ethnic group carries Neisseria meningitidis before performing Hajj (33.3%).While the Syrian pilgrims were the most ethnic group carries Neisseria meningitidis after performing Hajj (20.6%). Serotypes of Neisseria meningitides isolated from Umrah and Hajj Visitors during 1430H season: Out of the 80 Neisseria meningitidis isolated from Umrah Visitors during the Umrah season, 20 were of Poly (A, B, C, D) serotypes, 8 were of serotype B, 13 were of serotype Poly 2 (X, Y,Z), 2 were of serotype W135 and 37 were non typable, figure. (1). While, out of 152Neisseria meningitidis isolated from pilgrims during the Hajj season, 42 were of Poly (A, B,C,D) serotypes, 16 were of serotype B, 17 were of serotype Poly 2 (X, Y,Z) and 70 were non typable, figure. (2). Antimicrobial Susceptibility of Neisseria meningitides isolated from Umrah during 1430H season: For the 80 Neisseria meningitides isolates isolated from Umrah Visitors in this study, all of them were susceptible to Cefotaxim, Ceftriaxone and Meropenem antibiotics. While, in the other hand, (8.3%) before Umrah and (5.4%) after

5 Ashgar et al. 145 Figure 1. Serotypes of N. meningitidisisolated before and after Umrah Figure 1. Serotypes of N. meningitidisisolated before and after Hajj Umrah were resistant to Azithromycin antibiotic, table (3). Antimicrobial Susceptibility of Neisseria meningitidis isolated from Pilgrims during the Hajj 1430H season: For the 152 Neisseria meningitides isolates isolated from Pilgrims in this study, all of them were susceptible to Cefotaxime antibiotic. Most of them [(81%) before Hajj and (97.1%) after Hajj] were sensitive to Ceftriaxone antibiotic, while in the other hand, (8.3%)before Hajj and (10.3%) after Hajj were resistant to Azithromycin antibiotic, table (4). DISCUSSION The congregation of so many people during Umrah and Hajj seasons from different parts of the world in unavoidably overcrowded conditions within a confined area for a defined period of time presents many public health

6 146. Glo. Adv. Res. J. Microbiol. Table 3. Antibiotic profile of N. meningitides isolated from Umrah during 1430H season Antibiotic Before Umrah After Umrah *S % R % S % R % Azithromycin Cefotaxime Ceftriaxone Ciprofloxacin Levofloxacin Meropenem Rifampicin *S= Number of sensitive; R= Number of resistant Table 4. Antibiotic profile of N. meningitides isolated from Pilgrims during the Hajj 1430H season Antibiotic Before Hajj After Hajj *S % R % S % R % Azithromycin Cefotaxime Ceftriaxone Ciprofloxacin Levofloxacin Meropenem Rifampicin *S= Number of sensitive; R= Number of resistant challenges and health risks are greatly increased, with potential for both local and international consequences. One of the main health problems correlated with these two seasons crowding is meningitis infection. This infection can be transmitted from infected people and more significantly from asymptomatic carriers with potentially pathogenic bacteria (PPB) such as; Neisseria meningitidis the other factor of concern is the possible spread of PPB strains not included in the current vaccines administered to all pilgrims before coming to Saudi Arabia particularly for N. meningitides. For this reason, 979 Umrah and 1433 pilgrims investigated for such infection that could not include in current vaccines administered in their countries or otherwise they will be acquisition of carriage. With the advances in molecular techniques, we are now able to link and identify strains from one place to another and it has been found that strains linked to Hajj outbreaks may be circulating for years before the onset of an outbreak (Molding et al., 2001).The latest outbreaks occurred during the Hajj pilgrimages of 2000 and 2001, when a shift from serogroup A disease to serogroup W135 occurred (Wilder-Smith et al., 2003). The Hajj provides the optimum conditions for exposure and colonization of N. meningitidis in nasopharynx. A high rate of colonization is a known prerequisite for epidemics (Caugant, 2008). That is why we concentrated on nasopharyngeal swabs and used a proper media viz. chocolate agar and MTM. N. meningitidis, a Gram-negative β-proteobacterium of the family Neisseriaceae, is an exclusive pathogen in humans, carried asymptomatically in the nasopharynx by 5% 10% of adults in nonepidemic periods (Stephens et al., 2007).After Umrah Turkish and Britain were the most ethnic groups carry Neisseria meningitides recorded significant values 6.20 and 14.29% (p=0.04 and 0.006, respectively) although those countries have population highly conserved in hygiene and personal cleanness. However, performing Umrah increases the carriage rate of PBB, since the carriage rate of N. meningitidis among the Umrah were more after performing Umrah than before performing Umrah. The prevalence of N. meningitidis was 24 before and 56 after Umrah indicated by highly significant value p= the transmission of the meningococcus is clearly elevated in close contact and

7 Ashgar et al. 147 crowded living conditions (e.g., barracks, dorms, pilgrimages). Human infections caused by meningococcus (Neisseria meningitidis) remain a serious health problem, infecting 500,000 to 1.2 million people and killing between 50,000 and 135,000 per year worldwide (Rouphael et al., 2012). The carriage rate of 75% in this study after Umrahis markedly higher than the 2.6% found in pilgrims returning to the United States after the 2001 Hajj (CDC, 2001). This discrepancy is unlikely to be explained by differences in study methodology alone but probably results from differences in living conditions, degree of overcrowding, or social activities during the Umrah. An international outbreak of meningococcal disease caused by Neisseria meningitidis W135 occurred in association with the Hajj pilgrimage in 2000 and 2001 (Taha et al., 2000), with a high attack rate not only among the pilgrims but also among household contacts of returning pilgrims (Hahne et al., 2002; Issack and Ragavoodoo, 2002 and Wilder-Smith et al., 2003). Previous studies suggest that these meningococcal serogroups were carried to the Middle East/Mediterranean region where meningococcal disease outbreaks subsequently occurred among Hajj pilgrims and across sub-saharan African countries (Trotter and Greenwood, 2007 and Halperin et al., 2012). Still Neisseria meningitidis W135 impose a threat to Umrah ; 2(3.6%) cases detected after Umrah in contrast nil before Umrah, or pilgrims; increased after Hajj by 7.4%. Saudi Arabia and other countries adopted the quadrivalent vaccine, serogroups other than A, C, W135 and Y may emerge. Carriage studies in Saudi Arabia showed that almost one third of the isolates were phenotypically nongroupable, not expressing a capsule, though genogrouping, by use of the capsular operon, of these has not, to date, been performed (Balkhy et al., 2003).Moreover, in this study non-typableserogroup was half of the isolates from Umrah and 54.8% in Hajj. Other serogroups may emerge, like serogroup B, for which no broad coverage vaccine is available or other serogroups such as X which was reported as unprecedented incidence of meningitis in Niger (Boisier et al., 2007).In 1988 during Hajj, few cases of serogroup B meningococcal meningitis were reported (El Bushra et al., 2000 and Balkhy et al., 2004).But in 1998, serogroup B caused 60% (25 out of 42) of disease. Countries with large Muslim populations have started to show a trend of increased serogroup B meningococcal disease; Umrah increased from 2 isolates before to 6 after Umrah. Our findings describing the meningococcal serogroup distribution are inconsistent with previous studies (Al-Mazrou et al., 2004; Memish et al., 2010; Caesar et al., 2013 and Ceyhan et al., 2013). In Egypt, which is the leading country regarding to Saudi Arabia for religious reasons (Tourism statistics, 2009), a shift from serogroup A to serogroup B predominance in meningococcal diseases was noted in 1998 (Nakhla et al., 2005).Also in Egypt, in laboratory based surveillance for bacterial meningitis from 1998 to 2004, 35% of meningococcal diseases were belonging to serogroup B (Afifi et al., 2007).In Turkey, a prospective study in children showed that 31% of cases of meningococcal disease were due to serogroup B (Ceyhan et al., 2008). The trends of increased serogroup B as a cause of meningococcal disease in neighboring countries in addition to the high mobility related Hajj and Umra should increase our preparedness to expect a sudden change in the etiology of meningococcal disease during the Hajj. Close and intensified efforts for monitoring carriage states of and local inhabitants should be emphasized. Preventive measures against meningococcal disease should be evaluated according to pilgrimage country of origin. Saudi Arabia should be an active member of a global meningococcal network, which allows the flow of information and experience across the globe. As a part of this network, a reference lab should be established in the western region of Saudi Arabia where the holy cities are located. Two important factors of concern complicate the clinical outcome of PPB carriage during Umrah season. First, the emergence and spread of several antimicrobial resistant strains among PPB in particular the emergence of antibiotic-resistant S. pneumoniae (such as; penicillin, macrolide, quinolone), ampicillin-resistant H. influenzae, macrolide-resistant S. pyogenes, and methicillin resistant S. aureus. The other factor of concern is the possible spread of PPB strains not included in the current vaccines administered to all pilgrims before coming to Saudi Arabia particularly for N. meningitidis and S. pnuemoniae. Laboratory surveillance data are critical to tracking the spread of less susceptible strains and to providing guidance in the empirical selection of antimicrobial agents. For all three bacterial meningitis pathogens, antimicrobial resistance has been identified, affecting the treatment of patients and chemoprophylaxis of close contacts. N. meningitidis isolates resistant to sulfonamides are common in many countries. Isolates resistant to rifampicin, penicillin, chloramphenicol, cotrimoxazole, ceftriaxone, and ciprofloxacin have also been identified (Wu et al., 2009). The most effective antibiotics against Neisseria meningitides isolated from Umrah were Cefotaxime, Ceftriaxone and Meropenem antibiotics. While the most effective antibiotics against Neisseria meningitidis isolated from pilgrims was Cefotaxime antibiotic. So, chemoprophylaxis with Cefotaxime, Ceftriaxone and Meropenem to eradicate nasopharyngeal carriage of the meningococcus is recommended for close contacts of patients to protect susceptible individuals and prevent further transmission. However, the same finding was also reported by Chang et al. (2012).

8 148. Glo. Adv. Res. J. Microbiol. ACKNOWLEDGMENT - We would like to thank the Center of Excellence for Hajj and Umrah Research at Umm Al-Qura University Makkah, Saudi Arabia for funding up this research. - Many thanks to the department of Microbiology Faculty of Medicine Umm Al-Qura University for their efforts in performing this study. - We also thank students of the 3rd year in the Faculty of Medicine and 3rd year in the Faculty of Applied Medical Science - Umm Al-Qura University for their efforts regarding sample collection and sample transport. REFERENCES Afifi S, Wasfy MO, Azab MA, Youssef FG, Pimentel G, Graham TW (2007). Laboratory-based surveillance of patientswith bacterial meningitis in Egypt (1998e2004). Eur. J. Clin. Microbiol. Infect Dis 2007;26:331e40. Al-Mazrou YY, Al-Jeffri MH, Abdalla MN, Elgizouli SA, Mishskas AA (2004). Changes in epidemiological pattern of meningococcal disease in Saudi Arabia. Does it constitute a new challenge for prevention and control? Saudi Med J 2004; 25:1410e3. Balkhy HH, Memish ZA, Almuneef MA, Osoba AO (2004). Neisseria meningitidis W-135 carriage during the Hajj season Scand J Infect Dis 2004; 36:264e8. Balkhy HH, Memish ZA, Osoba AO (2003). Meningococcal carriage among local inhabitants during the pilgrimage 2000e2001.Int J Antimicrob Agents 2003; 21:107e11. Boisier P, Nicolas P, Djibo S, Taha MK, Jeanne I, Maı nassara HB (2007). Meningococcal meningitis: unprecedented incidence of serogroup X- related cases in 2006 in Niger. Clin. Infect Dis 2007; 44:657e63. Caesar NM, Myers KA, Fan X (2013). Neisseria meningitidisserogroup B vaccine development. Microbiol. Pathog. 2013; 57: Cardozo D, Nascimento-Carvalho C, Souza F, Silva N (2006). Nasopharyngeal colonization and penicillin resistance among Pneumococcal strains: a worldwide 2004 update. Brazil J Infect Dis. 2006; 10(4): Caugant DA (2008). Genetics and evolution of Neisseria meningitidis: importance for the epidemiology of meningococcal disease. Infect Genet Evol 2008; 8:558e65. Centers for Disease Control and Prevention (CDC). Public health dispatch: update: assessment of risk for meningococcal disease associated with the Hajj MMWR Morb Mortal Wkly Rep 2001; 50: Ceyhan M, Celik M, Demir, Gurbuz V, Aycan AE, Unal S (2013). Acquisition of meningococcal serogroup W-135 carriage in Turkish Hajj pilgrims who had received the quadrivalent meningococcal polysaccharide vaccine. Clin. Vaccine Immunol. 2013; 1: Ceyhan M, Yildirim I, Balmer P, Borrow R, Dikici B, Turgut M (2008). A prospective study of etiology of childhood acute bacterial meningitis, Turkey.Emerg Infect Dis 2008; 14:1089e96. Chang Q, Tzeng YL, Stephens DS (2012). Meningococcal disease: changes in epidemiology and prevention.clinepidemiol 2012; 4: El Bushra HE, Hassan NM, Al-Hamdan NA, Al-Jeffri MH, Turkistani AM, Al-Jumaily A (1987). Determinants of case fatality rates of meningococcal disease during outbreaks in Makkah, Saudi Arabia, 1987e97. Epidemiol Infect 2000; 125:555e60. Fontanals D, Bou R, Pons I, Sanfeliu I, Dominguez A, Pineda V (2000). Prevalence of Haemophilus influenzaecarriers in the Catalan preschool population Eur. J. Clin. Microbiol. Infect Dis. 2000;19. Garcia-Rodriguez J, Martinez M (2002). Dynamics of Nasopharyngeal colonization by potential respiratory pathogens. J Antimicrobial Chemotherapy. 2002; 50: Hahne SJM, Gray SJ, Aguilera JF, Crowcroft NS, Nichols T, Kacymarski EB (2002). W135 meningococcal disease in England and Wales associated with Hajj 2000 and Lancet 2002; 359: Halperin SA, Bettinger JA, Greenwood B, Harrison LH, Jelfs J, Ladhani SN, McIntyre P, Ramsay ME, Safadi MA (2012). The changing and dynamic epidemiology of meningococcal disease. Vaccine 2012, 30(Suppl 2):B26 B36. Issack MI, Ragavoodoo C (2002). Hajj-related Neisseria meningitidissero group W135 in Mauritius. Emerg. Infect Dis. 2002; 8(3): Kadioglu A, Weiser J, Paton J, Andrew P (2008). The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nature Rev. 2008; 6: Melles D, Bogaet D, Gorkink R (2007). Nasopharyngeal co-colonization with Staphylococcus aureus and Streptococcus pneumoniae in children is bacterial genotype independent. Microbiol. 2007; 153: Memish ZA, Goubeaud A, Bröker M, Malerczyk C, Shibl AM (2010). Invasive meningococcal disease and travel. J. Infect Public Health. 2010; 3: Molding P, Buckhman A, Olcen P, Fredlund H (2001). Comparison of serogroup W135 meningococci isolated in Sweden during a 23-year period and those associated with a recent Hajj pilgrimage. J ClinMicrobiol 2001; 39:2695e9. Musher DM (2005). Streptococcus pneumoniae. In: Mandell GL, Bennett JE, Dolin R (eds). Principles and Practice of Infectious Diseases. 6 ed. New York, NY: Elsevier Churchill Livingstone, 2005: Nakhla I, Frenck RW, Teleb NA, El Oun S, Mansour H, Mahoney F (2005). The changing epidemiology of meningococcal meningitis after introduction of bivalent A/C polysaccharide vaccine into school-based vaccination program in Egypt. Vaccine 2005; 23:3288e93. Peacock S, de Silva I, Lowy F (2001). What determines nasal carriage of Staphylococcus aureus? Trends Microbiol. 2001; 9(12): Qureshi H, Gessner B, Leboulleux D, Hasan H, Alam S, Moulton L (2000). The Incidence of vaccine preventable influnenza-like illness and medication use among Pakistani pilgrims to the Hajj in Saudi Arabia.Vaccine.2000; 18. Rouphael NG, Stephens DS (2012). Neisseria meningitidis: biology, microbiology, and epidemiology. Methods Mol Biol. 2012; 799:1 20. Ruoff KL, Whiley RA, Beighton D (2003). Streptococcus. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH (eds). Manual of Clinical Microbiol.8 ed. Volume 1. Washington, D.C: ASM Press, Snedecor GM, Cochran WG (1982). Statistical methods-7th edition, Iowa state Univ., Press, Ames., loww3a, USA., 1982: pp Stephens DS, Greenwood B, Brandtzaeg P (2007). Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet. 2007; 369(9580): Taha MK, Achtman M, Alonso JM, Greenwood B, Ramsay M, Fox A (2000). Serogroup W135 meningococcal disease in Hajj pilgrims. Lancet 2000; 356:2159. Tenover F, Gaynes R (2000). The epidemiology of Staphylococcus infection. In: Fischetti V, Novick R, Ferretti J, Portnoy D, Rood J (eds). Gram-positive pathogens Washington American Society for Microbiol., 2000: Tourism statistics (2007). Saudi Arabia: MAS, Tourism Information and Research Center; Trotter CL, Greenwood BM (2007). Meningococcal carriage in the African meningitis belt. Lancet Infect Dis 2007, 7(12): Wilder-Smith A, Goh KT, Barkham T, Paton NI (2003). Hajj-associated outbreak strain of Neisseria meningitidisserogroup W135: estimates of the attack rate in a defined population and the risk of invasive disease developing in carriers. Clin. Infect Dis. 2003; 36:679e83. Wilder-Smith A, Memish Z (2003). Meningococcal disease and travel Int. J. Antimicrobial Agents 2003; 21:102-6.

9 Wu HM, Harcourt BH, Hatcher CP, Wei SC, Novak RT, Wang X, Juni BA, Glennen A, Boxrud DJ, Rainbow J, Schmink S, Mair RD, Theodore MJ, Sander M A, Miller TK, Kruger K, Cohn AC, Clark TA, Messonnier N E, Mayer LW, Lynfield R (2009). Emergence of ciprofloxacin-resistant Neisseria meningitidis in North America. New Eng J Med 2009; 360: Ashgar et al. 149

Neisseria meningitidis W-135 Carriage During the Hajj Season 2003

Neisseria meningitidis W-135 Carriage During the Hajj Season 2003 Scand J Infect Dis 36: 264/268, 2004 Neisseria meningitidis W-135 Carriage During the Hajj Season 2003 HANAN H. BALKHY 1,2, ZIAD A. MEMISH 1,3, MAHA A. ALMUNEEF 1,2 and ABIMBOLA O. OSOBA 4 From the Departments

More information

Serogroup W in Africa & travellers

Serogroup W in Africa & travellers Serogroup W in Africa & travellers Muhamed-Kheir TAHA Institut Pasteur 01/11/2016 2 childhood meningococcal meningitis caused by this serogroup. Three infants, two with bacteremia and one with septic arthritis

More information

Örebro University Hospital

Örebro University Hospital Örebro University Hospital Department of Laboratory Medicine Susanne Jacobsson Date: 2015-02-18 Page 1 (8) Neisseria meningitidis 2014 Annual report concerning serogroup, genosubtype and antibiotic susceptibility

More information

Sporadic Cases of Meningococcal Meningitis Serogroup W-135 Ethiopia, 2013

Sporadic Cases of Meningococcal Meningitis Serogroup W-135 Ethiopia, 2013 Clinical Neurology and Neuroscience 2017; 1(3): 70-75 http://www.sciencepublishinggroup.com/j/cnn doi: 10.11648/j.cnn.20170103.15 Sporadic Cases of Meningococcal Meningitis Serogroup W-135 Ethiopia, 2013

More information

Meningococcal Disease in Travellers

Meningococcal Disease in Travellers Meningococcal Disease in Travellers Please find product Prescribing Information at the end of this presentation Meningococcal disease A rare but potentially serious illness in travellers1 Caused by the

More information

Streptococcus Pneumoniae

Streptococcus Pneumoniae Streptococcus Pneumoniae (Invasive Pneumococcal Disease) DISEASE REPORTABLE WITHIN 24 HOURS OF DIAGNOSIS Per N.J.A.C. 8:57, healthcare providers and administrators shall report by mail or by electronic

More information

Environmental survival of Neisseria meningitidis

Environmental survival of Neisseria meningitidis Environmental survival of Neisseria meningitidis Yih-Ling Tzeng, Emory University L.E. Martin, Emory University David Stephens, Emory University Journal Title: Epidemiology and Infection Volume: Volume

More information

Meningococcal Disease a resurgence of an old foe?

Meningococcal Disease a resurgence of an old foe? Meningococcal Disease a resurgence of an old foe? To talk about NZ rates of meningococcal disease Changing serotypes Clinical presentations Meningococcal vaccines What is meningococcal disease? Important

More information

Meningococcal Invasive Disease

Meningococcal Invasive Disease Meningococcal Invasive Disease Communicable Disease Control Unit NOTE: The main difference between this and previous protocols is reporting and management of meningococcal conjunctivitis. Criteria for

More information

Respiratory Tract Infections and its Preventive Measures among Hajj Pilgrims, 2010: A Nested Case Control Study

Respiratory Tract Infections and its Preventive Measures among Hajj Pilgrims, 2010: A Nested Case Control Study www.ijpm.in www.ijpm.ir Respiratory Tract Infections and its Preventive Measures among Hajj Pilgrims, 2010: A Nested Case Control Study Mohammad Hassan Emamian, Ali Mohammad Hassani 1, Mansooreh Fateh

More information

Incidence per 100,000

Incidence per 100,000 Streptococcus pneumoniae Surveillance Report 2005 Oregon Active Bacterial Core Surveillance (ABCs) Office of Disease Prevention & Epidemiology Oregon Department of Human Services Updated: March 2007 Background

More information

This genus includes two species pathogenic for humans:

This genus includes two species pathogenic for humans: THE GENUS NEISSERIA Neisseriae are gramnegative cocci arranged in pairs, so they are diplococci. This genus includes two species pathogenic for humans: N. gonorrhoeae (s.c. gonococci) N. meningitidis (s.c.

More information

Laboratory-confirmed invasive meningococcal disease: effect of the Hajj vaccination policy, Saudi Arabia, 1995 to 2011

Laboratory-confirmed invasive meningococcal disease: effect of the Hajj vaccination policy, Saudi Arabia, 1995 to 2011 Research articles Laboratory-confirmed invasive meningococcal disease: effect of the Hajj vaccination policy, Saudi Arabia, 1995 to 2011 Z Memish (zmemish@yahoo.com) 1,2, R Al Hakeem 1, O Al Neel 1, K

More information

Meningococcal meningitis

Meningococcal meningitis Etiological Agent: Neisseria meningitis (1) Meningococcal meningitis By Tho Dao Transmission The transmission of Neisseria meningitis is through direct contact from person to person via droplets or throat

More information

9/12/2018. Meningococcal Disease and Meningococcal Vaccine. Neisseria meningitidis. Meningococcal Disease Pathogenesis. Aerobic gram-negative bacteria

9/12/2018. Meningococcal Disease and Meningococcal Vaccine. Neisseria meningitidis. Meningococcal Disease Pathogenesis. Aerobic gram-negative bacteria Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Meningococcal Disease and Meningococcal Vaccine Adult Track Chapter 14 Photographs and images included

More information

Benefits of the pneumococcal immunisation programme in children in the United Kingdom

Benefits of the pneumococcal immunisation programme in children in the United Kingdom Benefits of the pneumococcal immunisation programme in children in the United Kingdom 2006-2014 Professor Mary P E Slack mpeslack@gmail.com March 2015 Disclosure of interest The presenter has received

More information

Swiss National Reference Center for Meningococci. > 2014 Annual Report <

Swiss National Reference Center for Meningococci. > 2014 Annual Report < Swiss National Reference Center for Meningococci > 2014 Annual Report < Hp. Hinrikson, S. Emonet and J. Schrenzel* Hôpitaux Universitaires de Genève Laboratoire de Bactériologie Rue Gabrielle-Perret-Gentil

More information

Source: Portland State University Population Research Center (

Source: Portland State University Population Research Center ( Neisseria meningitidis Surveillance Report 2009 Oregon Active Bacterial Core Surveillance (ABCs) Office of Disease Prevention & Epidemiology Oregon Health Authority Updated: June 2011 Background The Active

More information

Background: Meningococcal Disease on Campus

Background: Meningococcal Disease on Campus Health Services 229.931.2235 OFFICE 229.931.2666 FAX health@canes.gsw.edu Overview of Meningococcal Disease 800 Georgia Southwestern State University Drive Americus, Georgia 31709-4379 Background: Meningococcal

More information

Appendix A: Disease-Specific Chapters

Appendix A: Disease-Specific Chapters Ministry of Health and Long-Term Care Infectious Diseases Protocol Appendix A: Disease-Specific Chapters Chapter: Haemophilus influenzae disease, all types, invasive Effective: May 2018 Haemophilus influenzae,

More information

Respiratory Multiplex Array. Rapid, simultaneous detection of 22 bacterial and viral pathogens of the upper and lower respiratory tract

Respiratory Multiplex Array. Rapid, simultaneous detection of 22 bacterial and viral pathogens of the upper and lower respiratory tract Rapid, simultaneous detection of 22 bacterial and viral pathogens of the upper and lower respiratory tract Rapid, simultaneous detection of 22 bacterial and viral pathogens within the upper and lower respiratory

More information

Örebro University Hospital

Örebro University Hospital Örebro University Hospital Department of Laboratory Medicine Susanne Jacobsson Date: 2016-03-15 Page 1 (9) Neisseria meningitidis 2015 Annual report concerning serogroup, genosubtype and antibiotic susceptibility

More information

Haemophilus influenzae and its invisibility cloak. Anna Strain Virology Supervisor/VPD Reference Center Coordinator June 5, 2018

Haemophilus influenzae and its invisibility cloak. Anna Strain Virology Supervisor/VPD Reference Center Coordinator June 5, 2018 Haemophilus influenzae and its invisibility cloak Anna Strain Virology Supervisor/VPD Reference Center Coordinator June 5, 2018 Haemophilus influenzae Gram negative aerobic coccobacilli Pfeiffer s Bacillus-

More information

Meningitis January Dr Andrew Lee Consultant in Communicable Disease Control, PHE Information in this slide set was correct as of 21.1.

Meningitis January Dr Andrew Lee Consultant in Communicable Disease Control, PHE Information in this slide set was correct as of 21.1. Meningitis January 2016 Dr Andrew Lee Consultant in Communicable Disease Control, PHE Information in this slide set was correct as of 21.1.16 Outline What is meningitis What causes it What are the signs

More information

Swiss National Reference Center for Meningococci. > 2015 Annual Report <

Swiss National Reference Center for Meningococci. > 2015 Annual Report < Swiss National Reference Center for Meningococci > 2015 Annual Report < Hp. Hinrikson, S. Emonet and J. Schrenzel* Hôpitaux Universitaires de Genève Laboratoire de Bactériologie Rue Gabrielle-Perret-Gentil

More information

Haemophilus influenzae

Haemophilus influenzae Haemophilus influenzae type b Severe bacterial infection, particularly among infants During late 19th century believed to cause influenza Immunology and microbiology clarified in 1930s Haemophilus influenzae

More information

MODELLING INFECTIOUS DISEASES. Lorenzo Argante GSK Vaccines, Siena

MODELLING INFECTIOUS DISEASES. Lorenzo Argante GSK Vaccines, Siena MODELLING INFECTIOUS DISEASES Lorenzo Argante GSK Vaccines, Siena lorenzo.x.argante@gmail.com GSK IN A NUTSHELL GSK VACCINES - GLOBAL PRESENCE SIENA RESEARCH AND DEVELOPMENT (R&D) SITE EXPLORATORY DATA

More information

Bacterial diseases caused by Streptoccus pneumoniae in children

Bacterial diseases caused by Streptoccus pneumoniae in children Bacterial diseases caused by Streptoccus pneumoniae in children Bactermia 85% Bacterial pneumonia 66% Bacterial meningitis 50% Otitis media 40% Paranasal sinusitis 40% 0% 10% 20% 30% 40% 50% 60% 70% 80%

More information

Changes to the Meningococcal C conjugate (MenC) vaccine schedule. Questions and Answers

Changes to the Meningococcal C conjugate (MenC) vaccine schedule. Questions and Answers Changes to the Meningococcal C conjugate (MenC) vaccine schedule Questions and Answers Background The meningococcal C (MenC) vaccination programme was first introduced into the UK routine immunisation

More information

Haemophilus influenzae, Invasive Disease rev Jan 2018

Haemophilus influenzae, Invasive Disease rev Jan 2018 Haemophilus influenzae, Invasive Disease rev Jan 2018 BASIC EPIDEMIOLOGY Infectious Agent Haemophilus influenzae (H. influenzae) is a small, Gram-negative bacillus, a bacterium capable of causing a range

More information

Carriage and transmission of Neisseria meningitidis

Carriage and transmission of Neisseria meningitidis Chapter 2 Carriage and transmission of Neisseria meningitidis Caroline L Trotter, Martin CJ Maiden Introduction Despite the fact that the meningococcus is a pathogen of global significance, causing the

More information

Pre-Lec. + Questions

Pre-Lec. + Questions Sheet 14 (part 2) made by : Majd abu-fares corrected by: Shatha khtoum date:8/11/2016 Pre-Lec. + Questions *Pus: secretion of {WBCs + product of WBCs + product of M.O} *WBCs can produce enzymes cytokines

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Challenges and Controversies in Vaccination TRAVEL VACCINES Resat Ozaras, MD, Professor, Istanbul University Cerrahpasa Medical School Infectious Dis. Dept. Risk of exposure The severity of the disease

More information

in the meningitis belt

in the meningitis belt Biological aspects of meningitis epidemics in the meningitis belt Dr Pierre NICOLAS Meningococcus Unit, WHO collaborating centre IMTSSA, Allée du médecin colonel Jamot Parc du Pharo BP 60109 13262 Marseille

More information

BACTERIAL MENINGITIS: A FIVE YEAR ( ) RETROSPECTIVE STUDY AT UNIVERSITY MALAYA MEDICAL CENTer (UMMC), KUALA LUMPUR, MALAYSIA

BACTERIAL MENINGITIS: A FIVE YEAR ( ) RETROSPECTIVE STUDY AT UNIVERSITY MALAYA MEDICAL CENTer (UMMC), KUALA LUMPUR, MALAYSIA BACTERIAL MENINGITIS: A FIVE YEAR (2001-2005) RETROSPECTIVE STUDY AT UNIVERSITY MALAYA MEDICAL CENTer (UMMC), KUALA LUMPUR, MALAYSIA H Erleena Nur, I Jamaiah, M Rohela and V Nissapatorn Department of Parasitology,

More information

Meningococcal Disease: Sporadic Cases, Risk Groups, Outbreaks and Their Management

Meningococcal Disease: Sporadic Cases, Risk Groups, Outbreaks and Their Management Meningococcal Disease: Sporadic Cases, Risk Groups, Outbreaks and Their Management Dr. Arvind Singh Kushwaha Associate Professor, Department of Community Medicine, Armed Forces Medical College, Pune, Maharashtra,

More information

Multicomponent MenB Vaccine (4CMenB): An Innovative Step In the Global Fight Against Serogroup B Meningococcal Disease

Multicomponent MenB Vaccine (4CMenB): An Innovative Step In the Global Fight Against Serogroup B Meningococcal Disease Multicomponent MenB Vaccine (4CMenB): An Innovative Step In the Global Fight Against Serogroup B Meningococcal Disease Jeffrey J. Stoddard, MD, FAAP Head, Global Medical Affairs Novartis Vaccines and Diagnostics

More information

Bacterial meningitis in adults: Host and pathogen factors, treatment and outcome Heckenberg, S.G.B.

Bacterial meningitis in adults: Host and pathogen factors, treatment and outcome Heckenberg, S.G.B. UvA-DARE (Digital Academic Repository) Bacterial meningitis in adults: Host and pathogen factors, treatment and outcome Heckenberg, S.G.B. Link to publication Citation for published version (APA): Heckenberg,

More information

PNEUMONIA : PROMISE FULFILLED? Regina Berba MD FPSMID

PNEUMONIA : PROMISE FULFILLED? Regina Berba MD FPSMID PNEUMONIA : PROMISE FULFILLED? Regina Berba MD FPSMID Objectives of Lecture Know the quality of current evidence based guidelines on immunization Appreciate the performance of pneumonia vaccines in terns

More information

Published by Centers for Disease Control (CDC) Archived on this site by permission of CDC, [url]http://www.cdc.gov/ncidod/eid[/url]

Published by Centers for Disease Control (CDC) Archived on this site by permission of CDC, [url]http://www.cdc.gov/ncidod/eid[/url] MSF Field Research Continuing effectiveness of serogroup a meningococcal conjugate vaccine, Chad, 2013 Authors Gamougam, K; Daugla, D M; Toralta, J; Ngadoua, C; Fermon, F; Page, A-L; Djingarey, M H; Caugant,

More information

Clinical Education Initiative MENINGOCOCCAL URETHRITIS. Speaker: Marguerite Urban, MD

Clinical Education Initiative MENINGOCOCCAL URETHRITIS. Speaker: Marguerite Urban, MD Clinical Education Initiative Support@ceitraining.org MENINGOCOCCAL URETHRITIS Speaker: Marguerite Urban, MD 9/27/2017 Meningococcal Urethritis [video transcript] [Intro music] 00:00:10 OK. So I have no

More information

Rôle et activités d un Centre Collaborateur de l OMS : le CC- OMS sur les méningites

Rôle et activités d un Centre Collaborateur de l OMS : le CC- OMS sur les méningites Rôle et activités d un Centre Collaborateur de l OMS : le CC- OMS sur les méningites Muhamed-Kheir Taha MD, PhD Invasive Bacterial Infections CNR des Méningocoques et Haemophilus influenzae WHOcc for meningitis

More information

Group B Streptococcus

Group B Streptococcus Group B Streptococcus (Invasive Disease) Infants Younger than 90 Days Old DISEASE REPORTABLE WITHIN 24 HOURS OF DIAGNOSIS Per N.J.A.C. 8:57, healthcare providers and administrators shall report by mail

More information

Meningococcal Disease Section 2: Epidemiology and Vaccination of Meningococcal Disease in Northern Ireland

Meningococcal Disease Section 2: Epidemiology and Vaccination of Meningococcal Disease in Northern Ireland Ulster Med J 2018;87(2):88-93 Review Article Meningococcal Disease Section 2: Epidemiology and Vaccination of Meningococcal Disease in Northern Ireland MeningoNI Forum (see page 87(2) 83 for full list

More information

Investigation of a Neisseria meningitidis Serogroup A Case in the Meningitis Belt. January 2017

Investigation of a Neisseria meningitidis Serogroup A Case in the Meningitis Belt. January 2017 January 2017 Investigation of a Neisseria meningitidis Serogroup A Case in the Meningitis Belt Introduction Since the progressive introduction of meningococcal serogroup A conjugate vaccine (MACV) in the

More information

Neisseria meningitidis Serogroup W-135 Isolated from Healthy Carriers and Patients in Sudan after the Hajj in 2000

Neisseria meningitidis Serogroup W-135 Isolated from Healthy Carriers and Patients in Sudan after the Hajj in 2000 Scand J Infect Dis 35: 230/233, 2003 Neisseria meningitidis Serogroup W-135 Isolated from Healthy Carriers and Patients in Sudan after the Hajj in 2000 MOHAMED ISSA 1,3, PAULA MÖLLING 2, MAGNUS UNEMO 2,

More information

Infections caused by Streptococcus pneumoniae are common worldwide

Infections caused by Streptococcus pneumoniae are common worldwide DOI 10. 5001/omj.2011.11 Serotype Prevalence and Penicillin-susceptibility of Streptococcus pneumoniae in Oman Mubarak M. Al-Yaqoubi, 1 Kamal M. Elhag 2 Received: 24 Sept 2010 / Accepted: 23 Dec 2010 OMSB,

More information

Global Burden of Meningococcal Disease. Prof. David Salisbury CB FRCP FRCPCH FFPH FMedSci. Centre for Global Health Security, Chatham House, London.

Global Burden of Meningococcal Disease. Prof. David Salisbury CB FRCP FRCPCH FFPH FMedSci. Centre for Global Health Security, Chatham House, London. Global Burden of Meningococcal Disease Prof. David Salisbury CB FRCP FRCPCH FFPH FMedSci. Centre for Global Health Security, Chatham House, London. Neisseria meningitidis Gram negative diplococci. Ten

More information

Meningococcal Meningitis

Meningococcal Meningitis Meningococcal Meningitis By Audrey Oh Etiologic Agent Neisseria meningitidis Transmission Neisseria meningitis is a bacterium that is often found in healthy, asymptomatic individuals [3]. Transmission

More information

National Institute for Communicable Diseases -- Weekly Surveillance Report --

National Institute for Communicable Diseases -- Weekly Surveillance Report -- Weekly Surveillance Report Week 43, 216 National Institute for Communicable Diseases -- Weekly Surveillance Report -- Page 2 Laboratory-Based Respiratory & Meningeal Disease Surveillance 3 Neisseria meningitidis

More information

Influenza a Common Viral Infection among Hajj Pilgrims: Time for Routine Surveillance and Vaccination

Influenza a Common Viral Infection among Hajj Pilgrims: Time for Routine Surveillance and Vaccination Influenza a Common Viral Infection among Hajj Pilgrims: Time for Routine Surveillance and Vaccination Hanan H. Balkhy, Ziad A. Memish, Saleh Bafaqeer, and Maha A.Almuneef Background: The annual Hajj pilgrimage

More information

MENINGITIS EPIDEMIC TRENDS in AFRICA. Mamoudou H. DJINGAREY, MD/MPH WHO-IST/WEST AFRICA OUAGADOUGOU

MENINGITIS EPIDEMIC TRENDS in AFRICA. Mamoudou H. DJINGAREY, MD/MPH WHO-IST/WEST AFRICA OUAGADOUGOU MENINGITIS EPIDEMIC TRENDS in AFRICA Mamoudou H. DJINGAREY, MD/MPH WHO-IST/WEST AFRICA OUAGADOUGOU Background Epidemic Meningococcal meningitis = a challenging public health threat in Africa. 1996: Devastating

More information

Can infant vaccination prevent pneumococcal meningitis outbreaks in sub-saharan Africa?

Can infant vaccination prevent pneumococcal meningitis outbreaks in sub-saharan Africa? Editorial Can infant vaccination prevent pneumococcal meningitis outbreaks in sub-saharan Africa? Author: James M Stuart, FFPH London School of Hygiene and Tropical Medicine, Keppel St, London WC1E 7HT,

More information

Acute Bacterial Meningitis in Infants and Children Epidemiology and Management

Acute Bacterial Meningitis in Infants and Children Epidemiology and Management REVIEW ARTICLE Pediatr Drugs 2011; 13 (6): 385-400 1174-5878/11/0006-0385/$49.95/0 ª 2011 Adis Data Information BV. All rights reserved. Acute Bacterial Meningitis in Infants and Children Epidemiology

More information

Raja NS, Parasakthi N, Puthucheary SD, Kamarulzaman A*

Raja NS, Parasakthi N, Puthucheary SD, Kamarulzaman A* Original Article www.jpgmonline.com Invasive meningococcal disease in the university of Malaya Medical Centre, Kuala Lumpur, Malaysia Raja NS, Parasakthi N, Puthucheary SD, Kamarulzaman A* Departments

More information

Gram-Negative Cocci :Neisseria & Vibrio

Gram-Negative Cocci :Neisseria & Vibrio Sulaimani University College of Pharmacy Microbiology Lec. 7 Gram-Negative Cocci :Neisseria & Vibrio Dr. Abdullah Ahmed Hama PhD. Microbiology/Molecular Parasitology abdullah.hama@spu.edu.iq 1 Neisseria

More information

The most up-to-date version of this policy can be viewed at the following website:

The most up-to-date version of this policy can be viewed at the following website: Page 1 of 10 Review Policy Objective To ensure that Healthcare Workers (HCWs) are aware of the actions and precautions necessary to minimise the risk of cross-infection and the importance of diagnosing

More information

Downloaded from:

Downloaded from: Granerod, J; Davison, KL; Ramsay, ME; Crowcroft, NS (26) Investigating the aetiology of and evaluating the impact of the Men C vaccination programme on probable meningococcal disease in England and Wales.

More information

ORIGINAL ARTICLE /j x

ORIGINAL ARTICLE /j x ORIGINAL ARTICLE 10.1111/j.1469-0691.2004.00869.x Invasive Streptococcus pneumoniae from Portugal: implications for vaccination and antimicrobial therapy I. Serrano, M. Ramirez, the Portuguese Surveillance

More information

Alberta Health and Wellness Public Health Notifiable Disease Management Guidelines August Pneumococcal Disease, Invasive (IPD)

Alberta Health and Wellness Public Health Notifiable Disease Management Guidelines August Pneumococcal Disease, Invasive (IPD) August 2011 Pneumococcal Disease, Invasive (IPD) Revision Dates Case Definition Reporting Requirements Remainder of the Guideline (i.e., Etiology to References sections inclusive) Case Definition August

More information

Shelter-based Meningococcal Disease Outbreak: Working together to treat and vaccinate

Shelter-based Meningococcal Disease Outbreak: Working together to treat and vaccinate Shelter-based Meningococcal Disease Outbreak: Working together to treat and vaccinate Barbara Giles, MSN, RN April Donahue, BSN, RN Denise De Las Nueces, MD, MPH Boston Health Care for the Homeless Program

More information

Annual Report of the National Center for Meningococci 2005

Annual Report of the National Center for Meningococci 2005 Annual Report of the National Center for Meningococci 2005 Béatrice Ninet, Peter Rohner, Jacques Schrenzel Hôpitaux Universitaires de Genève Laboratoire Central de Bactériologie 24 rue Micheli-du-Crest

More information

Methicillin-Resistant Staphylococcus aureus (MRSA) S urveillance Report 2008 Background Methods

Methicillin-Resistant Staphylococcus aureus (MRSA) S urveillance Report 2008 Background Methods Methicillin-Resistant Staphylococcus aureus (MRSA) Surveillance Report 2008 Oregon Active Bacterial Core Surveillance (ABCs) Office of Disease Prevention & Epidemiology Oregon Department of Human Services

More information

in control group 7, , , ,

in control group 7, , , , Q1 Rotavirus is a major cause of severe gastroenteritis among young children. Each year, rotavirus causes >500,000 deaths worldwide among infants and very young children, with 90% of these deaths occurring

More information

Haemophilus influenzae type B and Hib Vaccine Chapter 9

Haemophilus influenzae type B and Hib Vaccine Chapter 9 Haemophilus influenzae type B and Hib Vaccine Chapter 9 Haemophilus influenzae Aerobic gram-negative bacteria Polysaccharide capsule Six different serotypes (a-f) of polysaccharide capsule 95% of invasive

More information

Canadian College of Microbiologists. Syllabus for Examination Preparation for Fellows in Clinical Microbiology (FCCM)

Canadian College of Microbiologists. Syllabus for Examination Preparation for Fellows in Clinical Microbiology (FCCM) Canadian College of Microbiologists Syllabus for Examination Preparation for Fellows in Clinical Microbiology (FCCM) This syllabus has been prepared as a study guide for the written and oral components

More information

EDUCATIONAL COMMENTARY PERTUSSIS

EDUCATIONAL COMMENTARY PERTUSSIS EDUCATIONAL COMMENTARY PERTUSSIS Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits click on Earn CE Credits

More information

Of 142 cases where sex was known, 56 percent were male; of 127cases where race was known, 90 percent were white, 4 percent were

Of 142 cases where sex was known, 56 percent were male; of 127cases where race was known, 90 percent were white, 4 percent were Group B Streptococcus Surveillance Report 2014 Oregon Active Bacterial Core Surveillance (ABCs) Center for Public Health Practice Updated: November 2015 Background The Active Bacterial Core surveillance

More information

Invasive Bacterial Diseases in the Arctic. Tom Hennessy, MD, MPH Arctic Investigations Program October 2, 2015 Copenhagen

Invasive Bacterial Diseases in the Arctic. Tom Hennessy, MD, MPH Arctic Investigations Program October 2, 2015 Copenhagen Invasive Bacterial Diseases in the Arctic Tom Hennessy, MD, MPH Arctic Investigations Program October 2, 2015 Copenhagen Outline Introduction to Alaska International Circumpolar Surveillance Invasive bacterial

More information

ST2859 serogroup A meningococcal meningitis outbreak in Nouna Health District, Burkina Faso: a prospective study

ST2859 serogroup A meningococcal meningitis outbreak in Nouna Health District, Burkina Faso: a prospective study Tropical Medicine and International Health doi:10.1111/j.1365-3156.2008.02056.x volume 13 no 6 pp 861 868 june 2008 ST2859 serogroup A meningococcal meningitis outbreak in Nouna Health District, Burkina

More information

High Risk Conditions and Vaccination Gaps in Invasive Pneumococcal Disease Cases in Tennessee,

High Risk Conditions and Vaccination Gaps in Invasive Pneumococcal Disease Cases in Tennessee, High Risk Conditions and Vaccination Gaps in Invasive Pneumococcal Disease Cases in Tennessee, 2011-2016 Kinley Reed Candidate for Master of Public Health September 12, 2017 Outline Brief Introduction

More information

PREVENTION OF MENINGOCOCCAL MENINGITIS BY VACCINATION IN THE AFRICAN MENINGITIS BELT

PREVENTION OF MENINGOCOCCAL MENINGITIS BY VACCINATION IN THE AFRICAN MENINGITIS BELT PREVENTION OF MENINGOCOCCAL MENINGITIS BY VACCINATION IN THE AFRICAN MENINGITIS BELT Brian Greenwood London School of Hygiene & Tropical Medicine ADVAC, Annecy May 19 th 2014 Cytoplasmic proteins bacterium

More information

B 型嗜血感冒桿菌感染及 其疫苗 衛生署疾病管制局 中區傳染病防治醫療網 王任賢指揮官

B 型嗜血感冒桿菌感染及 其疫苗 衛生署疾病管制局 中區傳染病防治醫療網 王任賢指揮官 B 型嗜血感冒桿菌感染及 其疫苗 衛生署疾病管制局 中區傳染病防治醫療網 王任賢指揮官 Haemophilus influenzae type b Severe bacterial infection, particularly among infants During late 19th century believed to cause influenza Immunology and microbiology

More information

Meningococcal Disease Information and Investigation Guidelines

Meningococcal Disease Information and Investigation Guidelines Meningococcal Disease Information and Investigation Guidelines Table of Contents: 1) Disease Description... 2 2) Infectious Agent... 2 3) Symptoms... 2 4) Incubation Period... 2 5) Incidence... 3 6) Transmission...

More information

Biomed Environ Sci, 2018; 31(3):

Biomed Environ Sci, 2018; 31(3): Biomed Environ Sci, 2018; 31(3): 233-237 233 Letter to the Editor A Cross-sectional Survey Assessing Carriage of Streptococcus pneumoniae in a Healthy Population in Xinjiang Uygur Autonomous Region of

More information

Nancy Nazaire-Bermal,MD Fellow PPS, PIDSP

Nancy Nazaire-Bermal,MD Fellow PPS, PIDSP DISEASE CONTAINMENT IN PEDIATRICS: PRACTICAL APPLICATIONS SETTING UP THE FINAL DEFENSE Nancy Nazaire-Bermal,MD Fellow PPS, PIDSP Objectives To provide practical and rational approach in postexposure chemoprophylaxis

More information

Hans Jürgen Dornbusch

Hans Jürgen Dornbusch Epidemiology of Invasive Meningococcal Disease Hans Jürgen Dornbusch Infectious Vaccination Disease Working Working Group Group Severe bacterial infections Pneumococcus Haemophilus influenzae b 3 rd World!

More information

Impact of MenAfriVac in nine countries of the African meningitis belt, : an analysis of surveillance data

Impact of MenAfriVac in nine countries of the African meningitis belt, : an analysis of surveillance data Impact of MenAfriVac in nine countries of the African meningitis belt, 2010 15: an analysis of surveillance data Caroline L Trotter, Clément Lingani, Katya Fernandez, Laura V Cooper, André Bita, Carol

More information

Dr. Ayman Salem M Mubarak Assistant professor of Immunology

Dr. Ayman Salem M Mubarak Assistant professor of Immunology Dr. Ayman Salem M Mubarak Assistant professor of Immunology Department of Botany and Microbiology Faculty of science at King Saud University P.O.Box 2455, Riyadh 11451 Kingdom of Saudi Arabia Office 1B

More information

Content. Introduction. Overview of reported outbreaks in WHO African Region. Disease Surveillance and Response. Vol. 2 Issue 3, April 30, 2012

Content. Introduction. Overview of reported outbreaks in WHO African Region. Disease Surveillance and Response. Vol. 2 Issue 3, April 30, 2012 Vol. 2 Issue 3, April 30, 2012 Content Introduction Overview of reported outbreaks in the WHO African Region Cholera Meningitis Ongoing outbreaks Lassa Fever in Nigeria Typhoid in Zimbabwe Meningitis in

More information

Vaccines. Robert Read University of Southampton University Hospital Southampton

Vaccines. Robert Read University of Southampton University Hospital Southampton Vaccines Robert Read University of Southampton University Hospital Southampton Disclosures Non personal, non specific; Novartis-GSK Member, JCVI Editor in Chief, Journal of Infection, and Current Opinion

More information

Invasive pediatric Neisseria meningitidis infections

Invasive pediatric Neisseria meningitidis infections J Microbiol Immunol Infect. 2009;42:427-432 Invasive pediatric Neisseria meningitidis infections Pao-Lan Tuan, Wen-Chen Li, Yhu-Chering Huang, Cheng-Hsun Chiu, Tzou-Yien Lin Division of Pediatric Infectious

More information

Meningococcal Meningitis

Meningococcal Meningitis Meningococcal Meningitis By Lindsey Ream Etiologic Agent The disease meningococcal meningitis, also known as meningococcus, is caused by the bacteria Neisseria meningitidis (1). Disease occurs when the

More information

Lecture 4. Gonococci : 1) do not have capsules 2) They have plasmids 3) They cause genital infection 4) Ferment glucose only

Lecture 4. Gonococci : 1) do not have capsules 2) They have plasmids 3) They cause genital infection 4) Ferment glucose only Lecture 4 Genus Neisseriae The Neisseria species are gram negative cocci that usually occur in pairs, Neisseria gonorrhea gonococci and Neisseria meningitidis meningococci are pathogenic for human and

More information

Bacterial Meningitis Concerns in Collegiate Athletics.5 hr. CEU

Bacterial Meningitis Concerns in Collegiate Athletics.5 hr. CEU Bacterial Meningitis Concerns in Collegiate Athletics.5 hr. CEU This unit is designed to increase your understanding of a highly dangerous infection, and help you protect your student athletes from its

More information

Incidence per 100,

Incidence per 100, Group B Streptococcus Surveillance Report 2005 Oregon Active Bacterial Core Surveillance (ABCs) Office of Disease Prevention & Epidemiology Oregon Department of Human Services Updated: January 2007 Background

More information

1.3 Meningococcal Disease (Neisseria meningitidis) (invasive)

1.3 Meningococcal Disease (Neisseria meningitidis) (invasive) 1.3 Meningococcal Disease (Neisseria meningitidis) (invasive) Summary Number of cases, 214: 82 Number of cases, 213: 81 Number of cases, 212: 66 Crude incidence rate, 214:1.8/1, Between and 212, a marked

More information

Impact of meningococcal C conjugate vaccine in the UK

Impact of meningococcal C conjugate vaccine in the UK J. Med. Microbiol. Vol. 51 (22), 717 722 # 22 Society for General Microbiology ISSN 22-2615 REVIEW ARTICLE Impact of meningococcal C conjugate vaccine in the UK P. BALMER, R. BORROW and E. MILLER Meningococcal

More information

J. M. COLLARD 1 *, Z. MAMAN 2,A.ABANI 2,H.B.MAINASARA 1,S.DJIBO 1, H. YACOUBA 2,R.MAITOURNAM 2, F. SIDIKOU 1, P. NICOLAS 3, J.

J. M. COLLARD 1 *, Z. MAMAN 2,A.ABANI 2,H.B.MAINASARA 1,S.DJIBO 1, H. YACOUBA 2,R.MAITOURNAM 2, F. SIDIKOU 1, P. NICOLAS 3, J. Epidemiol. Infect. (2011), 139, 1656 1660. f Cambridge University Press 2011 doi:10.1017/s0950268810003092 SHORT REPORT Microbiological and epidemiological investigation of the Neisseria meningitidis serogroup

More information

Hawaii State Laboratories Required Submission Information for APHL RFP: Validation of the MALDI-TOF for the identification of Neisseria gonorrhoeae

Hawaii State Laboratories Required Submission Information for APHL RFP: Validation of the MALDI-TOF for the identification of Neisseria gonorrhoeae Hawaii State Laboratories Required Submission Information for APHL RFP: Validation of the MALDI-TOF for the identification of Neisseria gonorrhoeae 1. Please describe the laboratory s current MALDI-TOF

More information

Potential Impact of Conjugate Vaccine on the Incidence of Invasive Pneumococcal Disease among Children in Scotland

Potential Impact of Conjugate Vaccine on the Incidence of Invasive Pneumococcal Disease among Children in Scotland JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 2006, p. 1224 1228 Vol. 44, No. 4 0095-1137/06/$08.00 0 doi:10.1128/jcm.44.4.1224 1228.2006 Copyright 2006, American Society for Microbiology. All Rights Reserved.

More information

Bacterial infections of central nervous system Microbiology lec. #4 (bacteriology 1) Dr. Asem Shehabi

Bacterial infections of central nervous system Microbiology lec. #4 (bacteriology 1) Dr. Asem Shehabi Bacterial infections of central nervous system Microbiology lec. #4 (bacteriology 1) Dr. Asem Shehabi This sheet includes only extra information not mentioned in the slides So you should refer to the slides.

More information

Acute Communicable Disease Outbreaks among MSM, 2016

Acute Communicable Disease Outbreaks among MSM, 2016 Acute Communicable Disease Outbreaks among MSM, 2016 Benjamin Schwartz, MD Acute Communicable Disease Control Program Los Angeles County Department of Public Health bschwartz@ph.lacounty.gov (213) 240-7941

More information

Medicine - Dr. Hawar - Lecture 5 - CNS Infections I

Medicine - Dr. Hawar - Lecture 5 - CNS Infections I Medicine - Dr. Hawar - Lecture 5 - CNS Infections I Infections of the nervous system can be caused by viruses, bacteria, fungi or protozoa. They may affect the lining of the brain, CSF, brain parenchyma,

More information

CNS Infections. GBS Streptococcus agalactiae. Meningitis - Neonate

CNS Infections. GBS Streptococcus agalactiae. Meningitis - Neonate CNS Infections GBS Streptococcus agalactiae Bacterial meningitis - Pathophysiology - general Specific organisms - Age Hosts Treatment/Prevention Distinguish from viral disease Common commensal flora childbearing

More information

Prevalence/incidence of maternal group B streptococcal colonisation in European countries A systematic review

Prevalence/incidence of maternal group B streptococcal colonisation in European countries A systematic review Prevalence/incidence of maternal group B streptococcal colonisation in European countries A systematic review Egle Barcaite, MD, PhD student Department of Obstetrics and Gynaecology, Kaunas University

More information

Improving the prevention, diagnosis and clinical management of sepsis

Improving the prevention, diagnosis and clinical management of sepsis SEVENTIETH WORLD HEALTH ASSEMBLY A70/13 Provisional agenda item 12.2 13 April 2017 Improving the prevention, diagnosis and clinical management of sepsis Report by the Secretariat 1. The Executive Board

More information

ANTIBIOTIC GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED MENINGITIS AND ENCEPHALITIS IN ADULTS

ANTIBIOTIC GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED MENINGITIS AND ENCEPHALITIS IN ADULTS ANTIBIOTIC GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED MENINGITIS AND ENCEPHALITIS IN ADULTS Version 4.0 Date ratified February 2009 Review date February 2011 Ratified by Authors Consultation Evidence

More information

Meningococcal disease

Meningococcal disease THEME: School contagions Meningococcal disease BACKGROUND Despite significant advances in the prevention and management of Neisseria meningitidis infection, invasive meningococcal disease continues to

More information